GB9926437D0 - Pharmaceutical - Google Patents

Pharmaceutical

Info

Publication number
GB9926437D0
GB9926437D0 GB9926437A GB9926437A GB9926437D0 GB 9926437 D0 GB9926437 D0 GB 9926437D0 GB 9926437 A GB9926437 A GB 9926437A GB 9926437 A GB9926437 A GB 9926437A GB 9926437 D0 GB9926437 D0 GB 9926437D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB9926437A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB9926437A priority Critical patent/GB9926437D0/en
Publication of GB9926437D0 publication Critical patent/GB9926437D0/en
Priority to IL13945700A priority patent/IL139457A0/en
Priority to IL13945600A priority patent/IL139456A0/en
Priority to IL13945400A priority patent/IL139454A0/en
Priority to IL13945500A priority patent/IL139455A0/en
Priority to DE60016877T priority patent/DE60016877T2/en
Priority to EP00309718A priority patent/EP1097706A1/en
Priority to EP00309722A priority patent/EP1097719B1/en
Priority to ES00309722T priority patent/ES2233297T3/en
Priority to SK1671-2000A priority patent/SK16712000A3/en
Priority to AT00309722T priority patent/ATE285249T1/en
Priority to PT00309722T priority patent/PT1097719E/en
Priority to EP20000309719 priority patent/EP1097707A1/en
Priority to EP20000309720 priority patent/EP1097718A1/en
Priority to EP20040020972 priority patent/EP1481667A1/en
Priority to SK1672-2000A priority patent/SK16722000A3/en
Priority to SK1670-2000A priority patent/SK16702000A3/en
Priority to DK00309722T priority patent/DK1097719T3/en
Priority to CZ20004106A priority patent/CZ20004106A3/en
Priority to MYPI20005202A priority patent/MY141651A/en
Priority to AU71407/00A priority patent/AU781400B2/en
Priority to MYPI20005205A priority patent/MY140534A/en
Priority to AU71411/00A priority patent/AU781186B2/en
Priority to CZ20004107A priority patent/CZ20004107A3/en
Priority to CZ20004110A priority patent/CZ20004110A3/en
Priority to AU71409/00A priority patent/AU7140900A/en
Priority to ZA200006378A priority patent/ZA200006378B/en
Priority to ZA200006374A priority patent/ZA200006374B/en
Priority to ZA200006376A priority patent/ZA200006376B/en
Priority to AU71408/00A priority patent/AU781403B2/en
Priority to ZA200006375A priority patent/ZA200006375B/en
Priority to NZ508007A priority patent/NZ508007A/en
Priority to NO20005661A priority patent/NO20005661L/en
Priority to BR0005266-3A priority patent/BR0005266A/en
Priority to PE2000001187A priority patent/PE20010926A1/en
Priority to PE2000001185A priority patent/PE20010817A1/en
Priority to NZ508011A priority patent/NZ508011A/en
Priority to HU0004347A priority patent/HUP0004347A2/en
Priority to CN00137670A priority patent/CN1328824A/en
Priority to NZ508006A priority patent/NZ508006A/en
Priority to KR1020000065740A priority patent/KR20010051481A/en
Priority to CO00084519A priority patent/CO5680108A1/en
Priority to CNA2004100859558A priority patent/CN1636597A/en
Priority to PE2000001188A priority patent/PE20010925A1/en
Priority to CA002323191A priority patent/CA2323191A1/en
Priority to KR1020000065868A priority patent/KR20010086267A/en
Priority to NO20005618A priority patent/NO20005618L/en
Priority to CN00137665A priority patent/CN1320426A/en
Priority to CNA2004100713908A priority patent/CN1575816A/en
Priority to HU0004348A priority patent/HUP0004348A2/en
Priority to NZ508012A priority patent/NZ508012A/en
Priority to NO20005662A priority patent/NO20005662L/en
Priority to PE2000001186A priority patent/PE20010924A1/en
Priority to KR1020000065761A priority patent/KR20010082544A/en
Priority to HU0004350A priority patent/HUP0004350A2/en
Priority to CA002324484A priority patent/CA2324484A1/en
Priority to CA002323464A priority patent/CA2323464A1/en
Priority to CO00084521A priority patent/CO5680109A1/en
Priority to KR1020000065863A priority patent/KR20010082545A/en
Priority to CN00137671A priority patent/CN1322526A/en
Priority to CA002323183A priority patent/CA2323183A1/en
Priority to HU0004349A priority patent/HUP0004349A2/en
Priority to JP2000339853A priority patent/JP2001213802A/en
Priority to PL00343754A priority patent/PL343754A1/en
Priority to BR0005276-0A priority patent/BR0005276A/en
Priority to EA200001043A priority patent/EA006254B1/en
Priority to BR0005299-0A priority patent/BR0005299A/en
Priority to EA200001042A priority patent/EA200001042A3/en
Priority to JP2000339957A priority patent/JP2001247479A/en
Priority to JP2000339949A priority patent/JP2001247478A/en
Priority to JP2000339905A priority patent/JP2001206855A/en
Priority to EA200001044A priority patent/EA006242B1/en
Priority to PL00343755A priority patent/PL343755A1/en
Priority to US09/708,392 priority patent/US6734186B1/en
Priority to PL00343753A priority patent/PL343753A1/en
Priority to HK02102195.7A priority patent/HK1040626A1/en
Priority to HK02102197.5A priority patent/HK1040627A1/en
Priority to HK02103406.0A priority patent/HK1041646A1/en
Priority to US10/686,390 priority patent/US20040254153A1/en
Priority to US10/686,282 priority patent/US20050020547A1/en
Priority to US10/686,349 priority patent/US20050070499A1/en
Priority to KR1020040050972A priority patent/KR20040074022A/en
Priority to KR1020040050971A priority patent/KR20040074021A/en
Priority to KR1020040050973A priority patent/KR20040074023A/en
Priority to JP2004267669A priority patent/JP2005021167A/en
Priority to JP2004268608A priority patent/JP2005013237A/en
Priority to JP2004269732A priority patent/JP2005070055A/en
Priority to JP2004269807A priority patent/JP2005043377A/en
Priority to AU2005202166A priority patent/AU2005202166A1/en
Priority to AU2005202750A priority patent/AU2005202750A1/en
Priority to JP2005233224A priority patent/JP2005350482A/en
Ceased legal-status Critical Current

Links

GB9926437A 1999-11-08 1999-11-08 Pharmaceutical Ceased GB9926437D0 (en)

Priority Applications (91)

Application Number Priority Date Filing Date Title
GB9926437A GB9926437D0 (en) 1999-11-08 1999-11-08 Pharmaceutical
IL13945700A IL139457A0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
IL13945600A IL139456A0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
IL13945400A IL139454A0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
IL13945500A IL139455A0 (en) 1999-11-08 2000-11-02 Compounds for the treatment of female sexual dysfunction
DE60016877T DE60016877T2 (en) 1999-11-08 2000-11-03 NEP inhibitors for the treatment of female sexual disorders
EP00309718A EP1097706A1 (en) 1999-11-08 2000-11-03 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
EP00309722A EP1097719B1 (en) 1999-11-08 2000-11-03 NEP inhibitors for the treatment of female sexual dysfunction
ES00309722T ES2233297T3 (en) 1999-11-08 2000-11-03 INHIBITORS OF THE NEUTRAL ENDOPEPTIDASE (NEP) FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION.
SK1671-2000A SK16712000A3 (en) 1999-11-08 2000-11-03 Compounds for the treatment of female sexual dysfunction
AT00309722T ATE285249T1 (en) 1999-11-08 2000-11-03 NEP INHIBITORS FOR THE TREATMENT OF FEMALE SEXUAL DISORDERS
PT00309722T PT1097719E (en) 1999-11-08 2000-11-03 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
EP20000309719 EP1097707A1 (en) 1999-11-08 2000-11-03 Treatment of female sexual dysfunction
EP20000309720 EP1097718A1 (en) 1999-11-08 2000-11-03 NPY antagonists for the treatment of female sexual dysfunction
EP20040020972 EP1481667A1 (en) 1999-11-08 2000-11-03 NEP inhibitors for the treatment of female sexual dysfunction
SK1672-2000A SK16722000A3 (en) 1999-11-08 2000-11-03 Compounds for the treatment of female sexual dysfunction
SK1670-2000A SK16702000A3 (en) 1999-11-08 2000-11-03 Compounds for the treatment of female sexual dysfunction
DK00309722T DK1097719T3 (en) 1999-11-08 2000-11-03 Use of compounds for the treatment of female sexual dysfunction
CZ20004106A CZ20004106A3 (en) 1999-11-08 2000-11-06 Compounds for treating sexual dysfunction in women
MYPI20005202A MY141651A (en) 1999-11-08 2000-11-06 Nep inhibitors for the treatment of female sexual dysfunction
AU71407/00A AU781400B2 (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
MYPI20005205A MY140534A (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
AU71411/00A AU781186B2 (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
CZ20004107A CZ20004107A3 (en) 1999-11-08 2000-11-06 Compounds for treating sexual dysfunction in women
CZ20004110A CZ20004110A3 (en) 1999-11-08 2000-11-06 Compounds for treating sexual dysfunction in women
AU71409/00A AU7140900A (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
ZA200006378A ZA200006378B (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction.
ZA200006374A ZA200006374B (en) 1999-11-08 2000-11-06 Compound for the treatment of female sexual dysfunction.
ZA200006376A ZA200006376B (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction.
AU71408/00A AU781403B2 (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction
ZA200006375A ZA200006375B (en) 1999-11-08 2000-11-06 Compounds for the treatment of female sexual dysfunction.
NZ508007A NZ508007A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction that potentiate cAMP activity and is an inhibitor of neuropeptide-Y (NPY)
NO20005661A NO20005661L (en) 1999-11-08 2000-11-07 Components for the treatment of female sexual dysfunction
BR0005266-3A BR0005266A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
PE2000001187A PE20010926A1 (en) 1999-11-08 2000-11-07 USEFUL ENDOPEPTIDASE INHIBITING COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
PE2000001185A PE20010817A1 (en) 1999-11-08 2000-11-07 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
NZ508011A NZ508011A (en) 1999-11-08 2000-11-07 Compounds that inhibit phosphodiesterase activity which results in potentiation of cAMP or cGMP to promote smooth muscle vasodilation
HU0004347A HUP0004347A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CN00137670A CN1328824A (en) 1999-11-08 2000-11-07 Compound for curing female sexual disorder
NZ508006A NZ508006A (en) 1999-11-08 2000-11-07 Compounds that potentiate cAMP responses for treatment of female impotence
KR1020000065740A KR20010051481A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
CO00084519A CO5680108A1 (en) 1999-11-08 2000-11-07 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
CNA2004100859558A CN1636597A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
PE2000001188A PE20010925A1 (en) 1999-11-08 2000-11-07 NEUROPEPTIDE INHIBITING COMPOUNDS AND USEFUL FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
CA002323191A CA2323191A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
KR1020000065868A KR20010086267A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
NO20005618A NO20005618L (en) 1999-11-08 2000-11-07 Components for the treatment of female sexual dysfunction
CN00137665A CN1320426A (en) 1999-11-08 2000-11-07 Compound for treatment of female sexual dysfuction
CNA2004100713908A CN1575816A (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
HU0004348A HUP0004348A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
NZ508012A NZ508012A (en) 1999-11-08 2000-11-07 Compounds that potentiate cAMP and is an inhibitor of NEP (neutral endopeptidase) (enkaplinhalinase)
NO20005662A NO20005662L (en) 1999-11-08 2000-11-07 Components for the treatment of female sexual dysfunction
PE2000001186A PE20010924A1 (en) 1999-11-08 2000-11-07 USEFUL PHOSPHODIESTERASE INHIBITING COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
KR1020000065761A KR20010082544A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
HU0004350A HUP0004350A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CA002324484A CA2324484A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CA002323464A CA2323464A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
CO00084521A CO5680109A1 (en) 1999-11-08 2000-11-07 COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
KR1020000065863A KR20010082545A (en) 1999-11-08 2000-11-07 Compounds for the Treatment of Female Sexual Dysfunction
CN00137671A CN1322526A (en) 1999-11-08 2000-11-07 Compound for treating female sexual dysfunction
CA002323183A CA2323183A1 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
HU0004349A HUP0004349A2 (en) 1999-11-08 2000-11-07 Compounds for the treatment of female sexual dysfunction
JP2000339853A JP2001213802A (en) 1999-11-08 2000-11-08 Compound for treating female sexual dysfunction
PL00343754A PL343754A1 (en) 1999-11-08 2000-11-08 Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agent, method of identifying said agent, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
BR0005276-0A BR0005276A (en) 1999-11-08 2000-11-08 Compounds for the treatment of female sexual dysfunction
EA200001043A EA006254B1 (en) 1999-11-08 2000-11-08 I:npy inhibitor for treating female sexual dysfunction
BR0005299-0A BR0005299A (en) 1999-11-08 2000-11-08 Compounds for the treatment of female sexual dysfunction
EA200001042A EA200001042A3 (en) 1999-11-08 2000-11-08 CONNECTIONS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
JP2000339957A JP2001247479A (en) 1999-11-08 2000-11-08 Compound for treatment of female sexual dysfunction
JP2000339949A JP2001247478A (en) 1999-11-08 2000-11-08 Compound for treatment of female sexual dysfunction
JP2000339905A JP2001206855A (en) 1999-11-08 2000-11-08 Compound for treatment of female sexual dysfunction
EA200001044A EA006242B1 (en) 1999-11-08 2000-11-08 Nep inhibitors for the treatment of female sexual disfunction
PL00343755A PL343755A1 (en) 1999-11-08 2000-11-08 Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agent, method of identifying said agend, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
US09/708,392 US6734186B1 (en) 1999-11-08 2000-11-08 Compounds for the treatment of female sexual dysfunction
PL00343753A PL343753A1 (en) 1999-11-08 2000-11-08 Pharmacological composition, application of an agent in production of a drug, method of therapeutically treating female patients, testing method in order to identify said agend, method of identifying said agent, diagnosing method, diagnostic composition, animal model for use in identification of said agent and method of obtaining a drug
HK02102195.7A HK1040626A1 (en) 1999-11-08 2002-03-22 Compounds for the treatment of female sexual dysfunction
HK02102197.5A HK1040627A1 (en) 1999-11-08 2002-03-22 Compounds for the treatment of female sexual dysfunction
HK02103406.0A HK1041646A1 (en) 1999-11-08 2002-05-04 Compounds for the treatment of female sexual dysfunction
US10/686,390 US20040254153A1 (en) 1999-11-08 2003-10-15 Compounds for the treatment of female sexual dysfunction
US10/686,282 US20050020547A1 (en) 1999-11-08 2003-10-15 Compounds for the treatment of female sexual dysfunction
US10/686,349 US20050070499A1 (en) 1999-11-08 2003-10-15 Compounds for the treatment of female sexual dysfunction
KR1020040050972A KR20040074022A (en) 1999-11-08 2004-07-01 Compounds for the Treatment of Female Sexual Dysfunction
KR1020040050971A KR20040074021A (en) 1999-11-08 2004-07-01 Compounds for the Treatment of Female Sexual Dysfunction
KR1020040050973A KR20040074023A (en) 1999-11-08 2004-07-01 Compounds for the Treatment of Female Sexual Dysfunction
JP2004267669A JP2005021167A (en) 1999-11-08 2004-09-15 Assay method for identifying agent for treating female sexual dysfunction (fsd), method and kit for detecting female sexual dysfunction and non-human animal model of female sexual dysfunction
JP2004268608A JP2005013237A (en) 1999-11-08 2004-09-15 Assaying method for identifying agent for treating female sexual dysfunction (fsd), method and kit for detecting female sexual dysfunction, and non-human animal model of female sexual dysfunction
JP2004269732A JP2005070055A (en) 1999-11-08 2004-09-16 Assay method for identifying medicine for treatment of female sexual dysfunction (fsd), detecting method and kit for female sexual dysfunction, and non-human animal model of female sexual dysfunction
JP2004269807A JP2005043377A (en) 1999-11-08 2004-09-16 Medicine for treating female sexual dysfunction
AU2005202166A AU2005202166A1 (en) 1999-11-08 2005-05-18 Compounds for the Treatment of Female Sexual Dysfunction
AU2005202750A AU2005202750A1 (en) 1999-11-08 2005-06-23 Compounds for the treatment of female sexual dysfunction
JP2005233224A JP2005350482A (en) 1999-11-08 2005-08-11 Compound for treatment of fsd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9926437A GB9926437D0 (en) 1999-11-08 1999-11-08 Pharmaceutical

Publications (1)

Publication Number Publication Date
GB9926437D0 true GB9926437D0 (en) 2000-01-12

Family

ID=10864170

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9926437A Ceased GB9926437D0 (en) 1999-11-08 1999-11-08 Pharmaceutical

Country Status (2)

Country Link
GB (1) GB9926437D0 (en)
ZA (4) ZA200006378B (en)

Also Published As

Publication number Publication date
ZA200006378B (en) 2002-05-06
ZA200006376B (en) 2002-05-06
ZA200006375B (en) 2002-05-06
ZA200006374B (en) 2002-05-06

Similar Documents

Publication Publication Date Title
PL351387A1 (en) Pharmaceutical composition
PL351686A1 (en) Novel pharmaceutical
HUP0203585A3 (en) Pharmaceutical combinations
EG23858A (en) Drug combination
IL145632A0 (en) Pharmaceutical compounds
EG23937A (en) Novel pharmaceutical
GB9916434D0 (en) Pharmaceutical compounds
PL351135A1 (en) Novel pharmaceutical
GB9914255D0 (en) Pharmaceutical compounds
GB9915231D0 (en) Pharmaceutical complex
GB9903784D0 (en) Pharmaceutical compounds
EG23946A (en) Novel pharmaceutical
GB2373499B (en) Pharmaceutical compounds
GB9924990D0 (en) Medicaments
GB9929040D0 (en) Medicaments
GB9923933D0 (en) Novel pharmaceutical
GB9923934D0 (en) Novel pharmaceutical
GB9926437D0 (en) Pharmaceutical
GB9926434D0 (en) Pharmaceutical
GB9904935D0 (en) Medicaments
GB9929039D0 (en) Medicaments
GB9912197D0 (en) Novel pharmaceutical
GB9912195D0 (en) Novel pharmaceutical
GB9912196D0 (en) Novel pharmaceutical
SI1169298T1 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)